oa SA Pharmaceutical Journal - New drug focus : drug info

Volume 75, Issue 1
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



FosavanceTM contains the bisphosphonate, alendronate in combination with vitamin D in the form of cholecalciferol. The combination is indicated for the treatment of postmenopausal osteoporosis to reduce the risk of fractures, including those of the hip and spine.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error